Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.557034 
Contract referenceInst. Nac. de Cancer-2021-00388 
Contract description:MEDICAMENTOS EXCLUSIVOS 2DO TRIMESTRE- 2021 
Goods 
Contract Start:
17/09/2021 15:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
30/11/2021 08:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateAccepted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
Inst. Nac. de Cancer-CCC-PEEX-2021-0006 
MEDICAMENTOS EXCLUSIVOS 2DO TRIMESTRE- 2021 
MEDICAMENTOS EXCLUSIVOS 2DO TRIMESTRE- 2021 
FARMACIA 
DRES MALLEN GUERRA_EXT_CP001 
GoodsDominicana 
19,928,924 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
17/09/2021 15:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
31/12/2021 08:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
INSTITUTO NACIONAL DEL CANCER ROSA EMILIA SANCHEZ PEREZ DE TAVARES DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments

PEDIDO 2DO TRIMESTRE 2021

 
 
 1 
DO1.PCCNTR.1133529 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
19,928,924.000.000.000.0019,670,650.0019,928,924.00
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
1
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 100 MG INY (AVASTIN)100UD28,70028,6902,869,000.000.000.000.002,870,000.002,869,000.00
    
2
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 400 MG INY (AVASTIN)50UD114,758114,7585,737,900.000.000.000.005,737,900.005,737,900.00
    
3
51111717 - Trastuzumab
2.3.4.1.01CETUXIMAB 5 MG / 20 ML AMPOLLA (ERBITUX)90UD30,21530,2152,719,350.000.000.000.002,719,350.002,719,350.00
    
4
51111705 - Mitotano
2.3.4.1.01ERLOTINIB 150 MG COMP (TACERVA)60UD4,5005,310.7318,642.000.000.000.00270,000.00318,642.00
    
5
51111717 - Trastuzumab
2.3.4.1.01PERTUZUMAB 420 MG (PERJETA)6UD212,000246,4521,478,712.000.000.000.001,272,000.001,478,712.00
    
6
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 1,400 MG / 11.7 ML INY (MABTHERA)5UD78,40078,400392,000.000.000.000.00392,000.00392,000.00
    
7
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 100 MG / 10 ML INY (MABTHERA)30UD13,50013,500405,000.000.000.000.00405,000.00405,000.00
    
8
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 500 MG INY (MABTHERA)15UD67,20067,2001,008,000.000.000.000.001,008,000.001,008,000.00
    
9
51111717 - Trastuzumab
2.3.4.1.01TRASTUZUMAB 600 MG / 5 ML VIAL (HERCEPTIN)40UD107,810107,9084,316,320.000.000.000.004,312,400.004,316,320.00
    
10
51131506 - Eritropoyetina
2.3.4.1.01ERITROPOYECTINA 30,000 U.I. INY90UD7,6007,600684,000.000.000.000.00684,000.00684,000.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Investment
General Source
18,121,976.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.0118,121,976.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
1  118,121,976.00  DOPAgosto2021
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
20211118,121,976.00  DOP